Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
Innovations in Emergency Nursing: Transforming Emergency Care Through a Novel Nurse‐Driven ED Telehealth Express Care Service
MER-101-03, a multicenter, phase II study to compare MER-101 20mg tablets to intravenous zoledronic acid 4mg in prostate cancer patients.
- C. McHugh, K. Madigan, A. Walsh, J. Fox, T. Leonard, J. Quint
- MedicineJournal of clinical oncology : official journal…
- 22 September 2016
Orazol weekly therapy appears to be as effective as Zometa, based on the biomarkers analyzed, and a rapid decrease for all four biomarkers was seen at seven days, and was sustained throughout the study.
Abstract B57: Safety profile of zoledronic acid in a novel oral formulation
Results to date indicate Orazol is an effective and potentially safer alternative to IV ZA, which may substantially improve patients’ quality of life.
78 Facing forward – life after cancer: a multidisciplinary approach
- C. McHugh
- 1 September 2014
A Comparison of Modified Food Chaining and Simultaneous Presentation Plus Nonremoval of the Spoon to Treat Food Selectivity in Children with Autism Spectrum Disorder
- C. McHugh
- Psychology, Medicine
- 29 April 2019
A multielement design is used to compare a modified version of a commonly used treatment, food chaining, and an empirically validated ABA treatment to treat the food selectivity of 2 children with autism spectrum disorder (ASD).
MER-101 tablets: A pilot bioavailability study of a novel oral formulation of zoledronic acid
A tablet dosage form of zoledronic acid has been successfully developed which will allow once weekly treatment of patients and was well tolerated and there were no serious adverse events associated with its administration.